Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Naive Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02638090
What this trial is testing

Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung CancerNon-small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 120
Not applicableActive Not RecruitingNCT06846073
What this trial is testing

Early Combined Use of Dexamethasone Intravitreal Implant and Anti-VEGF in the Treatment of DME.

Who this might be right for
Diabetic Macular Edema (DME)
Second Affiliated Hospital, Zhejiang University, School of Medicine 70
Large-scale testing (Phase 3)Study completedNCT02780141
What this trial is testing

Intermittent Oral Dosing of ASP1517 in Erythropoieses Stimulating Agent (ESA)-Naive Hemodialysis Chronic Kidney Disease Patients With Anemia

Who this might be right for
ESA-naive Hemodialysis Chronic Kidney Disease Patients With Anemia
Astellas Pharma Inc 75
Testing effectiveness (Phase 2)Study completedNCT00700180
What this trial is testing

Avastin (Bevacizumab) in Combination With Carboplatin-Based Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer.

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 303
Large-scale testing (Phase 3)Study completedNCT00540449
What this trial is testing

TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.

Who this might be right for
HIV InfectionsHIV-1Human Immunodeficiency Virus Type 1
Tibotec Pharmaceuticals, Ireland 694
Large-scale testing (Phase 3)Study completedNCT00641043
What this trial is testing

Efficacy vs Placebo as Initial Combination Therapy With Pioglitazone

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 389
Early research (Phase 1)Study completedNCT01438320
What this trial is testing

Q-Trial in Patients With Hepatitis C

Who this might be right for
Chronic Hepatitis C
University of California, Los Angeles 34
Testing effectiveness (Phase 2)UnknownNCT04181489
What this trial is testing

Sintilimab in Combination With R-CHOP in Patients With Treatment-naive EBV-positive DLBCL, NOS

Who this might be right for
EBV-Positive DLBCL, Nos
The First Affiliated Hospital with Nanjing Medical University 55
Large-scale testing (Phase 3)UnknownNCT00006049
What this trial is testing

ZD 1839 Plus Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
AstraZeneca
Post-approval studies (Phase 4)Study completedNCT01689649
What this trial is testing

Assess Tolerability and Efficacy of Topiramate Monotherapy in Recently Diagnosed Patients With Epilepsy

Who this might be right for
Epilepsy
Janssen Research & Development, LLC 139
Testing effectiveness (Phase 2)Study completedNCT00088088
What this trial is testing

STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Stage IIIB Non-Small Cell Lung CancerStage IV Non-Small Cell Lung Cancer
Synta Pharmaceuticals Corp. 86
Large-scale testing (Phase 3)Study completedNCT01732796
What this trial is testing

IFN-free Combination Therapy in HCV-infected Patients Treatment-naive:HCVerso1

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 470
Not applicableStudy completedNCT00259389
What this trial is testing

Directly Observed Therapy for HIV Infected Adolescents

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Post-approval studies (Phase 4)Study completedNCT01702090
What this trial is testing

Early Access to Low-dose Ritonavir (TMC114/r) and Other Antiretrovirals (ARVs) for Treatment-naive or Early Treatment Experienced in HIV-1 Patients

Who this might be right for
HIV-1
Janssen-Cilag Ltd. 10
Post-approval studies (Phase 4)WithdrawnNCT02470650
What this trial is testing

Cost-effectiveness of Different Antiretroviral Treatment in Patients HIV Naive

Who this might be right for
Patient ComplianceAntiretroviral Therapy Intolerance
Juan A. Arnaiz
Not applicableStudy completedNCT03139630
What this trial is testing

COPANA - A09 PCSK 9 Substudy: Impact of Protease Inhibitors on PCSK9 Levels in Naive HIV-Infected Patients

Who this might be right for
HIV SeropositivityDyslipidemiasPCSK9
Franck Boccara 193
Testing effectiveness (Phase 2)Study completedNCT01310244
What this trial is testing

MTD Study PXD-101 in Combination With Paclitaxel + Carboplatin in Chemotherapy-Naive Patients With Stage IV NSCLC

Who this might be right for
Stage IV Non-small Cell Lung Cancer
Acrotech Biopharma Inc. 23
Testing effectiveness (Phase 2)UnknownNCT05038657
What this trial is testing

Atezolizumab Immunotherapy, in Immunotherapy Naive Patients With Urinary Tract Squamous Cell Carcinoma (UTSCC).

Who this might be right for
Squamous Cell CarcinomaUrinary Tract Cancer
University Hospital Southampton NHS Foundation Trust 36
Large-scale testing (Phase 3)Study completedNCT00002230
What this trial is testing

A Randomized, Placebo-Controlled Study of the Safety and Efficacy of Efavirenz, Didanosine, and Stavudine in Combination With or Without Hydroxyurea in Antiretroviral Naive or Experienced HIV-Infected Patients

Who this might be right for
HIV Infections
Northwestern University 100
Testing effectiveness (Phase 2)Ended earlyNCT03858972
What this trial is testing

Tesetaxel Plus Reduced Dose of Capecitabine in Patients With HER2 Negative, HR Positive, LA/MBC

Who this might be right for
Breast Cancer
Odonate Therapeutics, Inc. 152
Next Page